Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biovail gains US rights to Wellbutrin XL from Glaxo after antitrust review period ends
Biovail gains US rights to Wellbutrin XL from Glaxo after antitrust review period ends
Biovail gains US rights to Wellbutrin XL from Glaxo after antitrust review period ends
Submitted by
admin
on May 15, 2009 - 7:57am
Source:
Yahoo/AP
News Tags:
GSK
Wellbutrin
Biovail
antidepressants
Headline:
Biovail gains US rights to Wellbutrin XL from Glaxo after antitrust review period ends
Do Not Allow Advertisers to Use My Personal information
